-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2025.
- Transcode Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $13.4K, a 58.2% decline year-over-year.
- Transcode Therapeutics, Inc. annual Depreciation for 2024 was $90.9K, a 26.4% decline from 2023.
- Transcode Therapeutics, Inc. annual Depreciation for 2023 was $123K, a 25.2% increase from 2022.
- Transcode Therapeutics, Inc. annual Depreciation for 2022 was $98.6K, a 132% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)